Current challenges in the management of patients with sickle cell disease - A report of the Italian experience

Giovanna Russo, Lucia De Franceschi, Raffaella Colombatti, Paolo Rigano, Silverio Perrotta, Vincenzo Voi, Giovanni Palazzi, Carmelo Fidone, Alessandra Quota, Giovanna Graziadei, Antonello Pietrangelo, Valeria Pinto, Giovan Battista Ruffo, Francesco Sorrentino, Donatella Venturelli, Maddalena Casale, Francesca Ferrara, Laura Sainati, Maria Domenica Cappellini, Antonio PigaAurelio Maggio, Gian Luca Forni

Research output: Contribution to journalArticle

Abstract

Sickle cell disease (SCD) is an inherited red blood cell disorder caused by a structural abnormality of hemoglobin called sickle hemoglobin (HbS). Clinical manifestations of SCD are mainly characterized by chronic hemolysis and acute vaso-occlusive crisis, which are responsible for severe acute and chronic organ damage. SCD is widespread in sub-Saharan Africa, in the Middle East, Indian subcontinent, and some Mediterranean regions. With voluntary population migrations, people harboring the HbS gene have spread globally. In 2006, the World Health Organization recognized hemoglobinopathies, including SCD, as a global public health problem and urged national health systems worldwide to design and establish programs for the prevention and management of SCD. Herein we describe the historical experience of the network of hemoglobinopathy centers and their approach to SCD in Italy, a country where hemoglobinopathies have a high prevalence and where SCD, associated with different genotypes including ß-thalassemia, is present in the native population.

Original languageEnglish
Article number120
JournalOrphanet Journal of Rare Diseases
Volume14
Issue number1
DOIs
Publication statusPublished - May 30 2019

Fingerprint

Sickle Cell Anemia
Hemoglobinopathies
Mediterranean Region
Sickle Hemoglobin
Middle East
Thalassemia
Africa South of the Sahara
Hemolysis
Italy
Population
Hemoglobins
Public Health
Erythrocytes
Genotype
Genes

Keywords

  • Hemoglobin disorder
  • Hemoglobinopathy
  • Hydroxyurea
  • Migrants
  • Sickle cell disease
  • Sickle cell screening
  • Transfusion
  • Vaso-occlusion crisis

ASJC Scopus subject areas

  • Genetics(clinical)
  • Pharmacology (medical)

Cite this

Russo, G., De Franceschi, L., Colombatti, R., Rigano, P., Perrotta, S., Voi, V., ... Forni, G. L. (2019). Current challenges in the management of patients with sickle cell disease - A report of the Italian experience. Orphanet Journal of Rare Diseases, 14(1), [120]. https://doi.org/10.1186/s13023-019-1099-0

Current challenges in the management of patients with sickle cell disease - A report of the Italian experience. / Russo, Giovanna; De Franceschi, Lucia; Colombatti, Raffaella; Rigano, Paolo; Perrotta, Silverio; Voi, Vincenzo; Palazzi, Giovanni; Fidone, Carmelo; Quota, Alessandra; Graziadei, Giovanna; Pietrangelo, Antonello; Pinto, Valeria; Ruffo, Giovan Battista; Sorrentino, Francesco; Venturelli, Donatella; Casale, Maddalena; Ferrara, Francesca; Sainati, Laura; Cappellini, Maria Domenica; Piga, Antonio; Maggio, Aurelio; Forni, Gian Luca.

In: Orphanet Journal of Rare Diseases, Vol. 14, No. 1, 120, 30.05.2019.

Research output: Contribution to journalArticle

Russo, G, De Franceschi, L, Colombatti, R, Rigano, P, Perrotta, S, Voi, V, Palazzi, G, Fidone, C, Quota, A, Graziadei, G, Pietrangelo, A, Pinto, V, Ruffo, GB, Sorrentino, F, Venturelli, D, Casale, M, Ferrara, F, Sainati, L, Cappellini, MD, Piga, A, Maggio, A & Forni, GL 2019, 'Current challenges in the management of patients with sickle cell disease - A report of the Italian experience', Orphanet Journal of Rare Diseases, vol. 14, no. 1, 120. https://doi.org/10.1186/s13023-019-1099-0
Russo, Giovanna ; De Franceschi, Lucia ; Colombatti, Raffaella ; Rigano, Paolo ; Perrotta, Silverio ; Voi, Vincenzo ; Palazzi, Giovanni ; Fidone, Carmelo ; Quota, Alessandra ; Graziadei, Giovanna ; Pietrangelo, Antonello ; Pinto, Valeria ; Ruffo, Giovan Battista ; Sorrentino, Francesco ; Venturelli, Donatella ; Casale, Maddalena ; Ferrara, Francesca ; Sainati, Laura ; Cappellini, Maria Domenica ; Piga, Antonio ; Maggio, Aurelio ; Forni, Gian Luca. / Current challenges in the management of patients with sickle cell disease - A report of the Italian experience. In: Orphanet Journal of Rare Diseases. 2019 ; Vol. 14, No. 1.
@article{e359a525c72441e29bd0407895f932fa,
title = "Current challenges in the management of patients with sickle cell disease - A report of the Italian experience",
abstract = "Sickle cell disease (SCD) is an inherited red blood cell disorder caused by a structural abnormality of hemoglobin called sickle hemoglobin (HbS). Clinical manifestations of SCD are mainly characterized by chronic hemolysis and acute vaso-occlusive crisis, which are responsible for severe acute and chronic organ damage. SCD is widespread in sub-Saharan Africa, in the Middle East, Indian subcontinent, and some Mediterranean regions. With voluntary population migrations, people harboring the HbS gene have spread globally. In 2006, the World Health Organization recognized hemoglobinopathies, including SCD, as a global public health problem and urged national health systems worldwide to design and establish programs for the prevention and management of SCD. Herein we describe the historical experience of the network of hemoglobinopathy centers and their approach to SCD in Italy, a country where hemoglobinopathies have a high prevalence and where SCD, associated with different genotypes including {\ss}-thalassemia, is present in the native population.",
keywords = "Hemoglobin disorder, Hemoglobinopathy, Hydroxyurea, Migrants, Sickle cell disease, Sickle cell screening, Transfusion, Vaso-occlusion crisis",
author = "Giovanna Russo and {De Franceschi}, Lucia and Raffaella Colombatti and Paolo Rigano and Silverio Perrotta and Vincenzo Voi and Giovanni Palazzi and Carmelo Fidone and Alessandra Quota and Giovanna Graziadei and Antonello Pietrangelo and Valeria Pinto and Ruffo, {Giovan Battista} and Francesco Sorrentino and Donatella Venturelli and Maddalena Casale and Francesca Ferrara and Laura Sainati and Cappellini, {Maria Domenica} and Antonio Piga and Aurelio Maggio and Forni, {Gian Luca}",
year = "2019",
month = "5",
day = "30",
doi = "10.1186/s13023-019-1099-0",
language = "English",
volume = "14",
journal = "Orphanet Journal of Rare Diseases",
issn = "1750-1172",
publisher = "BioMed Central Ltd.",
number = "1",

}

TY - JOUR

T1 - Current challenges in the management of patients with sickle cell disease - A report of the Italian experience

AU - Russo, Giovanna

AU - De Franceschi, Lucia

AU - Colombatti, Raffaella

AU - Rigano, Paolo

AU - Perrotta, Silverio

AU - Voi, Vincenzo

AU - Palazzi, Giovanni

AU - Fidone, Carmelo

AU - Quota, Alessandra

AU - Graziadei, Giovanna

AU - Pietrangelo, Antonello

AU - Pinto, Valeria

AU - Ruffo, Giovan Battista

AU - Sorrentino, Francesco

AU - Venturelli, Donatella

AU - Casale, Maddalena

AU - Ferrara, Francesca

AU - Sainati, Laura

AU - Cappellini, Maria Domenica

AU - Piga, Antonio

AU - Maggio, Aurelio

AU - Forni, Gian Luca

PY - 2019/5/30

Y1 - 2019/5/30

N2 - Sickle cell disease (SCD) is an inherited red blood cell disorder caused by a structural abnormality of hemoglobin called sickle hemoglobin (HbS). Clinical manifestations of SCD are mainly characterized by chronic hemolysis and acute vaso-occlusive crisis, which are responsible for severe acute and chronic organ damage. SCD is widespread in sub-Saharan Africa, in the Middle East, Indian subcontinent, and some Mediterranean regions. With voluntary population migrations, people harboring the HbS gene have spread globally. In 2006, the World Health Organization recognized hemoglobinopathies, including SCD, as a global public health problem and urged national health systems worldwide to design and establish programs for the prevention and management of SCD. Herein we describe the historical experience of the network of hemoglobinopathy centers and their approach to SCD in Italy, a country where hemoglobinopathies have a high prevalence and where SCD, associated with different genotypes including ß-thalassemia, is present in the native population.

AB - Sickle cell disease (SCD) is an inherited red blood cell disorder caused by a structural abnormality of hemoglobin called sickle hemoglobin (HbS). Clinical manifestations of SCD are mainly characterized by chronic hemolysis and acute vaso-occlusive crisis, which are responsible for severe acute and chronic organ damage. SCD is widespread in sub-Saharan Africa, in the Middle East, Indian subcontinent, and some Mediterranean regions. With voluntary population migrations, people harboring the HbS gene have spread globally. In 2006, the World Health Organization recognized hemoglobinopathies, including SCD, as a global public health problem and urged national health systems worldwide to design and establish programs for the prevention and management of SCD. Herein we describe the historical experience of the network of hemoglobinopathy centers and their approach to SCD in Italy, a country where hemoglobinopathies have a high prevalence and where SCD, associated with different genotypes including ß-thalassemia, is present in the native population.

KW - Hemoglobin disorder

KW - Hemoglobinopathy

KW - Hydroxyurea

KW - Migrants

KW - Sickle cell disease

KW - Sickle cell screening

KW - Transfusion

KW - Vaso-occlusion crisis

UR - http://www.scopus.com/inward/record.url?scp=85066737263&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85066737263&partnerID=8YFLogxK

U2 - 10.1186/s13023-019-1099-0

DO - 10.1186/s13023-019-1099-0

M3 - Article

C2 - 31146777

AN - SCOPUS:85066737263

VL - 14

JO - Orphanet Journal of Rare Diseases

JF - Orphanet Journal of Rare Diseases

SN - 1750-1172

IS - 1

M1 - 120

ER -